SCHEMBL4671091

SCHEMBL4671091

CCC(NS(=O)(=O)N1CCN(c2ccc(Cl)cc2)CC1)C(=O)NO

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
MAPT P10636 3/20 0.45
MMP14 P50281 2/20 0.45
ADAMTS5 Q9UNA0 1/20 0.45
GAA P10253 1/20 0.43
HDAC1 Q13547 2/20 0.43
HDAC3 O15379 1/20 0.43
HDAC4 P56524 1/20 0.43
HDAC7 Q8WUI4 1/20 0.43
HDAC2 Q92769 1/20 0.43
HDAC10 Q969S8 1/20 0.43
HDAC11 Q96DB2 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
HDAC9 Q9UKV0 1/20 0.43
HDAC5 Q9UQL6 1/20 0.43
POLB P06746 1/20 0.43
TP53 P04637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4671098 1.00 SMN1; SMN2 (0.46) SMN1; SMN2MEN1KMT2AMAPTMMP14
SCHEMBL4677141 0.91 SMN1; SMN2 (0.45) SMN1; SMN2MEN1KMT2AMAPTMMP14
SCHEMBL4677143 0.91 SMN1; SMN2 (0.45) SMN1; SMN2MEN1KMT2AMAPTMMP14
SCHEMBL7324705 0.84 MEN1 (0.49) SMN1; SMN2MEN1KMT2AMAPTMMP14
SCHEMBL4675462 0.84 HDAC1 (0.41) SMN1; SMN2MEN1KMT2AMAPTMMP14
SCHEMBL4675456 0.84 HDAC1 (0.41) SMN1; SMN2MEN1KMT2AMAPTMMP14
SCHEMBL4674851 0.82 MMP1 (0.57) SMN1; SMN2MEN1KMT2AMAPTMMP14
SCHEMBL4674856 0.82 MMP1 (0.57) SMN1; SMN2MEN1KMT2AMAPTMMP14
SCHEMBL4675433 0.79 MMP1 (0.54) SMN1; SMN2MAPTMMP13
SCHEMBL4675437 0.79 MMP1 (0.54) SMN1; SMN2MAPTMMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0958287-B2 SULFAMIDE-METALLOPROTEASE INHIBITORS HOFFMANN LA ROCHE (CH) 2008-04-09 EP disclosed
EP-0958287-B1 SULFAMIDE-METALLOPROTEASE INHIBITORS HOFFMANN LA ROCHE (CH) 2002-09-11 EP disclosed
US-6376506-B1 REACTING SULFAMOYL OXAZOLIDONE WITH (1,2,3,4)-TETRAHYDRO-BETA-CARBOLINE TO FORM INHIBITOR; USED TO TREAT ARTHRITIS, OSTEOPOROSIS, PERIODONTAL DISEASE, CARDIOVASCULAR DISEASES, MULTIPLE SCLEROSIS, AND TUMORS SYNTEX (U.S.A.) LLC 2002-04-23 US disclosed
US-6143744-A Sulfamide-metalloprotease inhibitors SYNTEX (U.S.A.) INC. (US) 2000-11-07 US disclosed
US-5998412-A ANTIARTHRITIC AGENTS; OSTEOPOROSIS SYNTEX (U.S.A.) INC. (US) 1999-12-07 US disclosed